BME100 f2014:Group12 L5: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
 
(38 intermediate revisions by 6 users not shown)
Line 14: Line 14:
{| style="wikitable" width="700px"
{| style="wikitable" width="700px"
|- valign="top"
|- valign="top"
| [[Image:BME103student.jpg|100px|thumb|Peter Hillebrand]]
| [[Image:PeterHillebrand1.jpg|100px|thumb|Peter Hillebrand]]
| [[Image:BME103student.jpg|100px|thumb|Darci Botsch]]
| [[Image:DarciBotsch.jpg|100px|thumb|Darci Botsch]]
| [[Image:BME103student.jpg|100px|thumb|Devon Rusk]]
| [[Image:DevonRusk1.jpg|100px|thumb|Devon Rusk]]
| [[Image:BME103student.jpg|100px|thumb|Krishnaa Pradhan]]
| [[Image:KrishnaaPradhan.jpg|100px|thumb|Krishnaa Pradhan]]
| [[Image:BME103student.jpg|100px|thumb|Sebastian Fonseca]]
| [[Image:SebastianFonseca1.jpg|100px|thumb|Sebastian Fonseca]]
| [[Image:BME103student.jpg|100px|thumb|Jorge Espinoza]]
| [[Image:JorgeEspinoza.jpg|100px|thumb|Jorge Espinoza]]
|}
|}


Line 30: Line 30:
'''Smart Phone Camera Settings'''<br>
'''Smart Phone Camera Settings'''<br>
<!-- The type of smart phone you used and how you adjusted the camera settings, if applicable. If you used more than one phone, make an additional list. -->
<!-- The type of smart phone you used and how you adjusted the camera settings, if applicable. If you used more than one phone, make an additional list. -->
* Type of Smartphone:
* Type of Smartphone: iPhone 5c
** Flash:
** Flash: No flash
** ISO setting:
** ISO setting: Default.
** White Balance:  
** White Balance: Auto.
** Exposure:
** Exposure: Auto.
** Saturation:
** Saturation: Auto.
** Contrast:
** Contrast: Auto.




'''Calibration'''<br>
'''Calibration'''<br>
<!-- INSTRUCTIONS: In the space below, briefly describe how to set up your camera in front of the fluorimeter. Add a PHOTO of this set-up for bonus points. -->
<!-- INSTRUCTIONS: In the space below, briefly describe how to set up your camera in front of the fluorimeter. Add a PHOTO of this set-up for bonus points. -->
Open up the camera on the smartphone and adjust the settings to fit the settings described above. Place the smartphone in the cradle and adjust the height of the fluorimeter in order for the camera to be able to take a picture of the drop sideways. One should be able to see the side of the plate and the drop. Adjust the distance of smartphone in the cradle and the drop in order to be able to have the best possible image that is close to the drop but is not blurry. 


<!-- INSTRUCTIONS: Type the distance between your phone cradle and the drop after the equal sign. -->
<!-- INSTRUCTIONS: Type the distance between your phone cradle and the drop after the equal sign. -->
* Distance between the smart phone cradle and drop =
* Distance between the smart phone cradle and drop = 6 cm




Line 49: Line 50:
{| {{table}} width=700
{| {{table}} width=700
|-
|-
| row 1 cell 1 || row 1 cell 2 || row 1 cell 3 || row 1 cell 4
| '''Concentration of 2X Calf Thymus DNA solution(micrograms/mL)''' || '''Volume of the 2X DNA solution (μL)''' || '''Volume of the SYBR GREEN I Dye Solution (μL)''' || '''Final DNA concentration in SYBR Green I solution (μg/mL)'''
|-
|-
| row 2 cell 1 || row 2 cell 2 || row 2 cell 3 || row 2 cell 4
| 5 || 80 || 80 || 2.5
|-
|-
| row 3 cell 1 || row 3 cell 2 || row 3 cell 3 || row 3 cell 4
| 2 || 80 || 80 || 1
|-
| 1 || 80 || 80 || 0.5
|-
| 0.5 || 80 || 80 || 0.25
|-
| 0.25 || 80 || 80 || 0.125
|-
| 0|| 80 || 80 || 0
|}
|}


Line 61: Line 70:


'''Placing Samples onto the Fluorimeter'''
'''Placing Samples onto the Fluorimeter'''
# ''[Instructions: Step one, in your OWN words]''
# Locate the smooth side of the glass slide using gloves.
# ''[Instructions: Step two, in your own words]''
# Turn the fluorimeter on.
# ''[Instructions: Step three, in your own words]''
# Smooth side facing down, place a slide into the fluorimeter.
# ''[Instructions: Step etc., in your own words]''
# With the camera app on, put the smartphone on the cradle. Set the camera timer for three seconds.
# Make sure the the camera view of the slide is nearly edge-on. If needed, adjust the fluorimeter height.
# In the middle of the slide on the first two clear circles, place 80 uL drop of SYBR Green I solution.
# On top of the SYBR Green I solution drop, place 80uL of the Sample/calibration solution.
# Make sure the light illuminates the center of the drop and the drop is focused on the light of the other side. The slide and be adjusted for this step.
# Record the distance between the smartphone and the fluorimeter so the drop is viewed closely, but still in focus.
# With the flap up, cover the lightbox.
# Double check to make sure the drop is focused.
# Take the picture. To do this, lower the flap and depress the dimer on the camera.
# Discard of the 160 uL drop from the slide into the liquid waste container.
# Move the slide to the center of the next two circles.
# Repeat the procedures with the slide for all of the five possible measurement positions.
# When the procedures have been carried out, all slides must be placed in the SHARPS container.


<br>
<br>
Line 74: Line 95:
<!-- INSTRUCTIONS: (1) Show ONE image where you drew a circle around the droplet with the freehand tool for any sample with *no* DNA. (2) Show ONE image where you drew a circle around the droplet with the freehand tool for a sample *with* DNA (positive signal). -If you include more than two images, you will not receive any additional credit. -->
<!-- INSTRUCTIONS: (1) Show ONE image where you drew a circle around the droplet with the freehand tool for any sample with *no* DNA. (2) Show ONE image where you drew a circle around the droplet with the freehand tool for a sample *with* DNA (positive signal). -If you include more than two images, you will not receive any additional credit. -->


'''Negative PCR Sample'''
[[Image: Negative_PCR_Drop.png|400px|Description of image]]
'''Positive_PCR_Drop.png'''


[[Image: Positive_PCR_Drop.png|400px|Description of image]]


'''Image J Values for All Calibrator Samples'''  
'''Image J Values for All Calibrator Samples'''  
Line 80: Line 107:


[[Image: Calibrationtablegroup12.png|700px|Description of image]]
[[Image: Calibrationtablegroup12.png|700px|Description of image]]
Due to time constraints in the lab, only one trial for each concentration was recorded.
[[Image: Screen_Shot_2014-11-05_at_10.13.25_AM.png‎ |700px|Description of image]]
Because only one trial was carried out, a standard deviation is not applicable.


[[Image:Table Lab 5.png|700px|Description of image]]
[[Image:Table Lab 5.png|700px|Description of image]]
Line 85: Line 120:
[[Image:Table3 group12 lab5.png|700px|Description of image]]
[[Image:Table3 group12 lab5.png|700px|Description of image]]


TABLE GOES HERE
[[Image:Table 4 Group 12 PCR.png|700px|Description of image]]


Due to time constraints in the lab, only one trial for each concentration was recorded. The value for this trial is used for the mean.
[[Image:Concentration of PCR Product G12.png|700px|Description of image]]


'''Calibration curve'''<br>
'''Calibration curve'''<br>
Line 92: Line 131:




[[Image:Screen_Shot_2014-10-29_at_11.42.38_AM.png|700px|Description of image]]
[[Image:Screen_Shot_2014-11-05_at_10.01.08_AM.png‎|700px|Description of image]]




'''PCR Results Summary'''
'''PCR Results Summary'''
<!-- INSTRUCTIONS: You completed 8 PCR reactions and used the SYBR Green I staining and imaging technique to measure the amount of amplified DNA in each PCR reaction. You used a standard curve (based on known concentrations of calf thymus DNA) to convert INTDEN values into DNA concentration. Your positive control and negative control samples should be used as '''threshold''' values for determining whether an unknown (patient) sample is truly positive or negative. Replace the underscore with your claculated initial concentration values.-->
<!-- INSTRUCTIONS: You completed 8 PCR reactions and used the SYBR Green I staining and imaging technique to measure the amount of amplified DNA in each PCR reaction. You used a standard curve (based on known concentrations of calf thymus DNA) to convert INTDEN values into DNA concentration. Your positive control and negative control samples should be used as '''threshold''' values for determining whether an unknown (patient) sample is truly positive or negative. Replace the underscore with your claculated initial concentration values.-->
* Our positive control PCR result was ____ μg/mL
* Our positive control PCR result was 34.92 μg/mL
* Our negative control PCR result was ____ μg/mL
* Our negative control PCR result was -8.172 μg/mL


<u>Observed results</u>
<u>Observed results</u>
<!-- INSTRUCTIONS: Replace the underscore with each patient ID. After the colon, write both a qualitative (what the images looked like) and a quantitative description (μg/mL) of what you observed -->
<!-- INSTRUCTIONS: Replace the underscore with each patient ID. After the colon, write both a qualitative (what the images looked like) and a quantitative description (μg/mL) of what you observed -->
* Patient _____ :  
* Patient 50958 : The drops in the images for this patient did not glow. The drop was not florescent because there was no dsDNA present. The patient's concentration results were closer to the negative control. The images for patient 50985 did not show any florescence, indicating that the patient was negative. The DNA concentration for patient 50958 was found to be -0.597 μg/mL.     
* Patient _____ :
* Patient 95193 : The drops in the images for this patient did not glow.The drop was not florescent because there was no dsDNA present. This patient's concentration results were also much closer to the negative control. The images for patient 95193 did not show any florescence, indicating that the patient was negative.The DNA concentration for patient 95193 was found to be -0.660 μg/mL.   


<u>Conclusions</u>
<u>Conclusions</u>
<!-- INSTRUCTIONS: Compare each patient's results to the positive control value and the negative control value. Draw a final conclusion for each patient (positive or negative) and explain why you made that conclusion. -->
<!-- INSTRUCTIONS: Compare each patient's results to the positive control value and the negative control value. Draw a final conclusion for each patient (positive or negative) and explain why you made that conclusion. -->
* Patient _____ :
* Patient 50958 : This patient's DNA concentration results were much closer to the negative control value and the drop was not florescent because there was no dsDNA present and it did not glow. The patient tested negative. 
* Patient _____ :
* Patient 95193 : This patient's DNA concentration results were much closer to the negative control value and the drop was not florescent because there was no dsDNA present and it did not glow. This patient also tested negative.
 




Line 119: Line 157:
<!-- INSTRUCTIONS: This content is from PCR Lab D. Write a summary, at least five sentences long, about the disease SNP in your own words. -->
<!-- INSTRUCTIONS: This content is from PCR Lab D. Write a summary, at least five sentences long, about the disease SNP in your own words. -->


SNP rs16991654 is a variation commonly found in Homo sapiens and is located on the 21:34360656 chromosome and is found in the Homo sapiens species. It is of pathogenic significance due to it being linked to congenital long QT syndrome (LQTS), a heart rhythm disorder that can potentially cause fast, chaotic heartbeats. This SNP is also associated with the KCNE2 gene; KCNE2 is the gene ID that contains SNP rs16991654. KCNE2 stands for potassium voltage-gated channel, the most complex class of voltage-gated ion channels. KCNE2's functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume.


'''Primer Design and Testing'''
'''Primer Design and Testing'''
<!-- INSTRUCTIONS: Write a short summary of the results of your primer test. Underneath your summary, include a screen capture of the results web page. You may crop the image so that it only includes the relevant information. -->
<!-- INSTRUCTIONS: Write a short summary of the results of your primer test. Underneath your summary, include a screen capture of the results web page. You may crop the image so that it only includes the relevant information. -->


Initially, the group investigated the DNA sequence of the KCNE2 gene, specifically in the region where the rs16991654 polymorphism was present. Based on the nucleotide sequences immediately before  the mutation, the forward primers were created taking into account the 20 base pairs preceding the target nucleotide, and ending them with the first nitrogenous base of the non-diseased and the diseased forms of the nucleotide. Then, the same procedure was followed to determine the DNA sequences for the reverse primers. One of the differences in this case was that the second DNA strand was used to create the reverse primer.Since this strand is directed from 3' to 5'(reading frame is from right to left), the sequence had to be reversed when written so that it's direction was shifted to 5' to 3'. For both the forward and the reverse primers of the disease sequence, the thymine at the start of the target nucleotide sequence had to be changed from a thymine to a cytosine. Posteriorly, the primers were evaluated using the UCSC In-Silico PCR program to ensure all the nitrogenous bases of the sequences were in the correct position.
Non-Disease Primer Test:


[[Image:Non-DiseasePrimer.jpg]]


Disease Primer Test:


[[Image:DiseasePrimer.jpg]]


<!-- Do not edit below this line -->
<!-- Do not edit below this line -->
|}
|}

Latest revision as of 23:23, 11 November 2014

BME 100 Fall 2014 Home
People
Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3
Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6
Course Logistics For Instructors
Photos
Wiki Editing Help


OUR TEAM

Peter Hillebrand
Darci Botsch
Devon Rusk
Krishnaa Pradhan
Sebastian Fonseca
Jorge Espinoza


LAB 5 WRITE-UP

Procedure

Smart Phone Camera Settings

  • Type of Smartphone: iPhone 5c
    • Flash: No flash
    • ISO setting: Default.
    • White Balance: Auto.
    • Exposure: Auto.
    • Saturation: Auto.
    • Contrast: Auto.


Calibration
Open up the camera on the smartphone and adjust the settings to fit the settings described above. Place the smartphone in the cradle and adjust the height of the fluorimeter in order for the camera to be able to take a picture of the drop sideways. One should be able to see the side of the plate and the drop. Adjust the distance of smartphone in the cradle and the drop in order to be able to have the best possible image that is close to the drop but is not blurry.

  • Distance between the smart phone cradle and drop = 6 cm


Solutions Used for Calibration

Concentration of 2X Calf Thymus DNA solution(micrograms/mL) Volume of the 2X DNA solution (μL) Volume of the SYBR GREEN I Dye Solution (μL) Final DNA concentration in SYBR Green I solution (μg/mL)
5 80 80 2.5
2 80 80 1
1 80 80 0.5
0.5 80 80 0.25
0.25 80 80 0.125
0 80 80 0



Placing Samples onto the Fluorimeter

  1. Locate the smooth side of the glass slide using gloves.
  2. Turn the fluorimeter on.
  3. Smooth side facing down, place a slide into the fluorimeter.
  4. With the camera app on, put the smartphone on the cradle. Set the camera timer for three seconds.
  5. Make sure the the camera view of the slide is nearly edge-on. If needed, adjust the fluorimeter height.
  6. In the middle of the slide on the first two clear circles, place 80 uL drop of SYBR Green I solution.
  7. On top of the SYBR Green I solution drop, place 80uL of the Sample/calibration solution.
  8. Make sure the light illuminates the center of the drop and the drop is focused on the light of the other side. The slide and be adjusted for this step.
  9. Record the distance between the smartphone and the fluorimeter so the drop is viewed closely, but still in focus.
  10. With the flap up, cover the lightbox.
  11. Double check to make sure the drop is focused.
  12. Take the picture. To do this, lower the flap and depress the dimer on the camera.
  13. Discard of the 160 uL drop from the slide into the liquid waste container.
  14. Move the slide to the center of the next two circles.
  15. Repeat the procedures with the slide for all of the five possible measurement positions.
  16. When the procedures have been carried out, all slides must be placed in the SHARPS container.


Data Analysis

Representative Images of Negative and Positive Samples

Negative PCR Sample

Description of image

Positive_PCR_Drop.png

Description of image

Image J Values for All Calibrator Samples

Description of image

Due to time constraints in the lab, only one trial for each concentration was recorded.


Description of image

Because only one trial was carried out, a standard deviation is not applicable.


Description of image

Description of image

Description of image

Due to time constraints in the lab, only one trial for each concentration was recorded. The value for this trial is used for the mean.


Description of image

Calibration curve


Description of image


PCR Results Summary

  • Our positive control PCR result was 34.92 μg/mL
  • Our negative control PCR result was -8.172 μg/mL

Observed results

  • Patient 50958 : The drops in the images for this patient did not glow. The drop was not florescent because there was no dsDNA present. The patient's concentration results were closer to the negative control. The images for patient 50985 did not show any florescence, indicating that the patient was negative. The DNA concentration for patient 50958 was found to be -0.597 μg/mL.
  • Patient 95193 : The drops in the images for this patient did not glow.The drop was not florescent because there was no dsDNA present. This patient's concentration results were also much closer to the negative control. The images for patient 95193 did not show any florescence, indicating that the patient was negative.The DNA concentration for patient 95193 was found to be -0.660 μg/mL.

Conclusions

  • Patient 50958 : This patient's DNA concentration results were much closer to the negative control value and the drop was not florescent because there was no dsDNA present and it did not glow. The patient tested negative.
  • Patient 95193 : This patient's DNA concentration results were much closer to the negative control value and the drop was not florescent because there was no dsDNA present and it did not glow. This patient also tested negative.




SNP Information & Primer Design

Background: About the Disease SNP

SNP rs16991654 is a variation commonly found in Homo sapiens and is located on the 21:34360656 chromosome and is found in the Homo sapiens species. It is of pathogenic significance due to it being linked to congenital long QT syndrome (LQTS), a heart rhythm disorder that can potentially cause fast, chaotic heartbeats. This SNP is also associated with the KCNE2 gene; KCNE2 is the gene ID that contains SNP rs16991654. KCNE2 stands for potassium voltage-gated channel, the most complex class of voltage-gated ion channels. KCNE2's functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume.

Primer Design and Testing

Initially, the group investigated the DNA sequence of the KCNE2 gene, specifically in the region where the rs16991654 polymorphism was present. Based on the nucleotide sequences immediately before the mutation, the forward primers were created taking into account the 20 base pairs preceding the target nucleotide, and ending them with the first nitrogenous base of the non-diseased and the diseased forms of the nucleotide. Then, the same procedure was followed to determine the DNA sequences for the reverse primers. One of the differences in this case was that the second DNA strand was used to create the reverse primer.Since this strand is directed from 3' to 5'(reading frame is from right to left), the sequence had to be reversed when written so that it's direction was shifted to 5' to 3'. For both the forward and the reverse primers of the disease sequence, the thymine at the start of the target nucleotide sequence had to be changed from a thymine to a cytosine. Posteriorly, the primers were evaluated using the UCSC In-Silico PCR program to ensure all the nitrogenous bases of the sequences were in the correct position.

Non-Disease Primer Test:

Disease Primer Test: